Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)

Inclusion Criteria:

1. Male or female aged at least 18 years old.
2. Capable of giving written consent on an IRB-approved Informed Consent Form prior toany study-specific evaluation
3. Have a clinical diagnosis of SLE determined by the examining physician or a diagnosisof incomplete lupus determined by the examining physician
4. On a stable SLE treatment regimen consisting of a stable dosage of medications for aperiod of at least 30 days prior to testing

Exclusion Criteria:

1. Have clinical evidence of significant unstable or uncontrolled acute or chronicdiseases not related to SLE (i.e., diabetes, cardiovascular, pulmonary, hematologic,gastrointestinal, neurological, or infectious) which, in the opinion of the treatingphysician, could confound the results of the study or put the patient at undue risk
2. Have received intravenous glucocorticoids at a dosage of ≥ 500 mg daily within thepast month
3. Have current drug or alcohol abuse or dependence, or a history of drug or alcoholabuse or dependence within 364 days prior to Baseline
4. Pregnant or lactating.
5. Recent participation in a clinical trial with an experimental agent in the past 6weeks, or 5 half-lives of the study drug, whichever is longer
6. Any condition that in the opinion of the treating physician might interfere with theperformance of the LuGENE® test